Comprehensive M&A data with integrated detailed company information
 
Sign in
 
 Apellis Pharmaceuticals secures Series E funding led by Sectoral Asset ManagementDeal No 1909616521 
 
 
Deal overview Maximize this section Remove this section
 Deal typeMinority stake unknown % 
 Deal statusCompleted 
 
 Target nameCountryActivityBvD ID number 
 APELLIS PHARMACEUTICALS INC.USCommercial physical and biological researchUS271537290 
 
Last data update: 23/08/2017 6:09 PM (CEDT)